Open AccessEvaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms
Author(s) -
Ginger D. Constantine,
Dennis A. Revicki,
Risa Kagan,
James A. Simon,
Shelli Graham,
Brian Bernick,
Sebastián Mirkin
Publication year - 2019
Publication title -
menopause
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.086
H-Index - 103
eISSN - 1530-0374
pISSN - 1072-3714
DOI - 10.1097/gme.0000000000001261
Subject(s) - medicine , placebo , vasomotor , menopause , minimal clinically important difference , population , clinical trial , estrogen , quality of life (healthcare) , randomized controlled trial , gynecology , urology , pathology , alternative medicine , nursing , environmental health
The aim of this study was to determine the clinical meaningfulness of TX-001HR in reducing moderate to severe vasomotor symptoms (VMS) in menopausal women with a uterus.